Associate Director for Biosimilars and Therapeutic Biologics
US Food and Drug Administration
Silver Spring, Maryland
Dr. Yow-Ming Wang is currently the Associate Director for Biosimilars and Therapeutic Biologics and leading Therapeutic Biologics Program in the Immediate Office of Office of Clinical Pharmacology at CDER, FDA. From 2011 to September 2017, Dr. Wang served as the team leader of Biologics Team in Division III of Clinical Pharmacology; her team was responsible for reviewing submissions of therapeutic biologics in three clinical divisions. Prior to joining the FDA, she worked in the pharmaceutical industry with experience in small molecules and large molecules which included at Amgen from 2004 to 2011, and for 11 years at Vertex Pharmaceuticals and at Parke-Davis Pharmaceutical Research combined. She received her PhD degree from The Ohio State University College of Pharmacy with a research focus on Pharmacokinetics and Biopharmaceutics.
Disclosure information not submitted.